Tapentadol in Pain Management: A μ-Opioid Receptor Agonist and Noradrenaline Reuptake Inhibitor

Author： Hartrick Craig T.   Rozek Richard J.  

Publisher： Adis International

ISSN： 1172-7047

Source： CNS Drugs, Vol.25, Iss.5, 2011-05, pp. : 359-370

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacological Properties of Novel Cyclic Pentapeptides with μ-opioid Receptor Agonist Activity

By  

Medicinal Chemistry, Vol. 10, Iss. 2, 2014-03 ,pp. : 154-161

Bentham Science Publishers

Access to resources Recommend Favorite

Reboxetine: the first selective noradrenaline re-uptake inhibitor

By Kasper S.   Giamal N.E.   Hilger E.  

Expert Opinion on Pharmacotherapy, Vol. 1, Iss. 4, 2000-05 ,pp. : 771-782

Informa Healthcare

Access to resources Recommend Favorite

Atomoxetine: a selective noradrenaline reuptake inhibitor for the treatment of attention-deficit/hyperactivity disorder

By Kratochvil Christopher J   Vaughan Brigette S   Harrington Martin J   Burke William J  

Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 7, 2003-07 ,pp. : 1165-1174

Informa Healthcare

Access to resources Recommend Favorite

Duloxetine: a serotonin-noradrenaline re-uptake inhibitor for the treatment of stress urinary incontinence

By Zinner Norman R  

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 9, 2003-09 ,pp. : 1559-1566

Informa Healthcare

Access to resources Recommend Favorite

Structure-activity Relationship, Conformation and Pharmacology Studies of Morphiceptin Analogues - Selective μ-Opioid Receptor Ligands

By  

Mini Reviews in Medicinal Chemistry, Vol. 2, Iss. 6, 2002-12 ,pp. : 565-572

Bentham Science Publishers

Access to resources Recommend Favorite